The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023

Table of Contents

1 Executive Summary

2 Introduction to OTC Pharmaceuticals

• 2.1 Over-the-Counter or Behind-the-Counter: What are OTC Pharmaceuticals?
• 2.2 Key Features of OTC Pharmaceuticals
• 2.3 OTC Switching
• 2.4 Manufacture and Distribution of OTC Pharmaceuticals
• 2.5 Regulation of OTC Pharmaceuticals
  • 2.5.1 United States
  • 2.5.2 Japan
  • 2.5.3 European Union
  • 2.5.4 Other Countries
• 2.6 Major Therapeutic Areas for OTC Pharmaceuticals
  • 2.6.1 Analgesics
    • 2.6.1.1 Internal Analgesics
    • 2.6.1.2 External Analgesics
  • 2.6.2 Cough, Cold, and Allergy Products
  • 2.6.3 Gastrointestinal Products
  • 2.6.4 Medicated Skincare Products
    • 2.6.4.1 Minor Cuts and Wounds
    • 2.6.4.2 Acne
    • 2.6.4.3 Rashes, Itchy Skin, Dermatitis and Eczema
    • 2.6.4.4 Cold Sores
    • 2.6.4.5 Warts
    • 2.6.4.6 Fungal Skin Infections
    • 2.6.4.7 Haemorrhoids
    • 2.6.4.8 Other Medicated Skincare Products
  • 2.6.5 Vitamins, Minerals & Supplements
  • 2.6.6 Other OTC Pharmaceuticals

3 The Global OTC Pharmaceutical Market

• 3.1 The World Market for OTC Pharmaceuticals Will Almost Double in Size by 2023
• 3.2 Which are the Largest OTC Therapeutic Categories?
• 3.3 The Leading Global OTC Pharmaceutical Manufacturers
  • 3.3.1 Johnson & Johnson
  • 3.3.2 Bayer
  • 3.3.3 GSK
  • 3.3.4 Novartis
  • 3.3.5 Wyeth
• 3.4 The Leading World OTC Brands
  • 3.4.1 Tylenol is the Only Global Billion Dollar OTC Brand
  • 3.4.2 Claritin Will Loose Its Dominant OTC Market Position
  • 3.4.3 Prilosec OTC Will Face Competition from Generics and New OTC Switches
• 3.5 The OTC Market is Rapidly Changing

4 SWOT Analysis of the OTC Pharmaceutical Industry

• 4.1 SWOT Chart
• 4.2 OTC Switching
• 4.3 Changing World Demographics
• 4.4 Developments in Wholesale and Retail Channels
• 4.5 Brand Identity and Private Labels
• 4.6 Will OTC Move Behind-the-Counter?
• 4.7 New Advertising Opportunities
• 4.8 Safety Concerns Over Misuse and Abuse of OTC Pharmaceuticals

5 The OTC Pharmaceutical Market by Geographical Area

• 5.1 The World OTC Market: China and India Will Increase Their Market Share
• 5.2 The US OTC Market
  • 5.2.1 The US OTC market in 2007
  • 5.2.2 The US OTC Market 2008-2013
• 5.3 The Japanese OTC Market
  • 5.3.1 The Japanese OTC Market in 2007
  • 5.3.2 Leading Japanese OTC Pharmaceutical Companies
    • 5.3.2.1 Taisho
    • 5.3.2.2 Takeda
    • 5.3.2.3 Daiichi Sankyo
    • 5.3.2.4 Lion
  • 5.3.3 The Japanese OTC Market 2008-2013
• 5.4 The European OTC Market
  • 5.4.1 The European OTC Market in 2007
  • 5.4.2 The European OTC market 2008-2013

6 Prescription-Only to OTC Switching

• 6.1 Recent Switching Activity
• 6.2 Gastrointestinal OTC Switching
• 6.3 Cough, Cold and Allergy OTC Switching
• 6.4 Analgesic OTC Switching
• 6.5 Medicated Skincare OTC Switching
• 6.6 Cholesterol-Lowering OTC Switching
• 6.7 Erectile Dysfunction OTC Switching
• 6.8 OTC Switching: A Continuing Trend in 2008-2023

7 Conclusions

List of Tables

• Table 3.1 World Sales Forecast ($bn) for OTC Pharmaceuticals 2006-2023
• Table 3.2 World Sales ($bn) for OTC Pharmaceuticals by Therapeutic Class 2007
• Table 3.3 World OTC Sales Forecast ($bn) by Therapeutic Category 2006-2023
• Table 3.4 Sales ($bn) of Top Five World OTC Manufacturing Companies 2007
• Table 3.5 Tylenol Worldwide Sales Forecast ($bn) 2007-2023
• Table 3.6 Claritin (OTC) Worldwide Sales Forecast ($bn) 2007-2023
• Table 3.7 Prilosec OTC Worldwide Sales Forecast ($bn) 2007-2023
• Table 4.1 SWOT Chart for the OTC Pharmaceutical Industry
• Table 4.2 World Population 2007-2023
• Table 4.3 China, India, US & Japan Population 2007-2023
• Table 4.4 GDP ($tr) US, Japan, China & India 2007-2023
• Table 5.1 OTC Pharmaceutical Sales by Country 2007
• Table 5.2 OTC Share of Pharma Market by Country 2007
• Table 5.3 Forecast World Sales ($bn) of OTC Pharmaceuticals by Country 2007-2023
• Table 5.4 OTC Therapeutic Areas US 2007
• Table 5.5 Largest selling OTC Pharmaceutical Brands in the US 2007
• Table 5.6 Sales ($m) of alli in the US 2007-2013
• Table 5.7 OTC Therapeutic Areas in Japan 2006
• Table 5.8 Leading Japanese OTC Manufacturing Companies 2006-07
• Table 5.9 Leading Cough, Cold and Allergy Brands in Japan 2008-2013
• Table 5.10 Sample European OTC Country Markets 2007
• Table 5.11 OTC Therapeutic Areas in Europe 2007
• Table 6.1 Selected Recent Prescription-Only to OTC Switches
• Table 6.2 Selected Possible Future OTC Switches
• Table 7.1 Leading OTC Country Markets 2007 & 2023

List of Figures

• Figure 1.1 World Sales Forecast ($bn) for OTC Pharmaceuticals 2007-2023
• Figure 2.1 The OTC Pharmaceutical Supply Chain
• Figure 3.1 World Sales Forecast ($bn) for OTC Pharmaceuticals 2007-2023
• Figure 3.2 World Sales Forecast ($bn) for Pharmaceuticals 2007-2023
• Figure 3.3 World OTC Sales Forecast ($bn) by Therapeutic Category 2007-2023
• Figure 3.4 Share of World OTC Pharmaceutical Sales by Therapeutic Category 2007
• Figure 3.5 Forecast Share of World OTC Sales by Therapeutic Category 2013
• Figure 3.6 Forecast Share of World OTC Sales by Therapeutic Category 2018
• Figure 3.7 Forecast Share of World OTC Sales by Therapeutic Category 2023
• Figure 3.8 Sales ($bn) of Top Five World OTC Manufacturing Companies 2007
• Figure 3.9 Tylenol, Prilosec OTC and Claritin (OTC) World Sales Forecast 2007-2023
• Figure 4.1 Populations of US, Japan, China and India 2007-2023
• Figure 4.2 Population Aged 65 or Over in US, Japan, China and India 2007-2023
• Figure 4.3 Populations % Aged 65 or Over in US, Japan, China and India 2007-2023
• Figure 4.4 Gross Domestic Product ($tr) for US, Japan, China and India 2007-2023
• Figure 5.1 Forecast Sales ($bn) of OTC Pharmaceuticals by Country 2007-2023
• Figure 5.2 Forecast Sales ($bn) of OTC Pharmaceutical by Country 2007-2023
• Figure 5.3 Market Share of World OTC Pharmaceutical Sales by Country 2007
• Figure 5.4 Forecast Market Share of World OTC Pharmaceuticals Sales by Country 2013
• Figure 5.5 Forecast Market Share of World OTC Pharmaceuticals Sales by Country 2018
• Figure 5.6 Forecast Market Share of World OTC Pharmaceuticals Sales by Country 2023
• Figure 5.7 Sales ($m) of alli in the US 2007-2013
• Figure 5.8 Leading Japanese OTC Pharmaceutical Companies 2006-07
• Figure 5.9 Leading Cough, Cold and Allergy Brands in Japan 2008-2013

Organisations Mentioned in this Report

• AmerisourceBergen
• Abbott Laboratories
• Adams Respiratory
• Alliance Boots
• AstraZeneca
• Barr
• Bayer
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Cardinal Health
• Celesio
• Chattem
• CNS
• Daiichi Sankyo
• Dr.Reddy' s
• Eisai
• European Medicines Agency (EMEA)
• Food and Drug Administration (FDA)
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Kowa
• Lion
• McKesson
• Medicines and Healthcare products Regulatory Agency (MHRA) (formerly MCA, (Medicines Control Agency))
• Menarini
• Merck & Co.
• Ministry of Health, Labour and Welfare (MHLW)
• Mission Pharmacal
• Novartis
• Perrigo
• Pfizer
• Phoenix Group
• Proctor & Gamble
• Ranbaxy
• Reckitt Benckiser
• Roche
• Rohto
• Sanofi-Aventis
• Santarus
• Sato
• Schering-Plough
• SSP
• Taisho
• Takeda
• TAP
• Target
• Teva
• Wal-Mart Stores
• Wyeth
• Zepharma